Financial Statements — CCCXW
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Cash & Equivalents | 84.67 | 1.14 | 1.23 | 0.00 |
| Accounts Receivable | 6.86 | -- | -- | -- |
| Inventory | 4.87 | -- | -- | -- |
| Total Current Assets | 464.88 | 1.53 | 1.63 | -- |
| Property, Plant & Equipment | 8.05 | -- | -- | -- |
| Goodwill | 9.32 | -- | -- | -- |
| Total Non-current Assets* | 147.74 | 419.74 | 416.43 | -- |
| Total Assets | 612.61 | 421.27 | 418.06 | 0.17 |
| Accounts Payable | 3.72 | -- | -- | -- |
| Total Current Liabilities | 23.55 | 36.70 | 0.10 | 0.22 |
| Total Non-current Liabilities* | 3.81 | 3.00 | 3.00 | 0.00 |
| Total Liabilities* | 27.36 | 39.70 | 3.10 | 0.22 |
| Retained Earnings | (261.35) | (37.98) | (0.20) | (0.07) |
| Total Stockholder Equity | 585.26 | (37.98) | (0.20) | (0.05) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Total Revenue | 9.46 | -- | -- | -- | -- |
| Cost of Revenue | 7.47 | -- | -- | -- | -- |
| Gross Profit | 1.99 | -- | -- | -- | -- |
| Research & Development | 9.95 | -- | -- | -- | -- |
| Selling, General & Admin | 26.32 | 0.55 | 1.23 | 0.19 | 0.02 |
| Total Operating Expenses | 35.57 | -- | -- | -- | -- |
| Operating Income | (33.58) | (0.55) | (7.28) | (0.19) | (0.02) |
| Pretax Income | (30.26) | -- | -- | -- | -- |
| Tax Provision | 0.00 | -- | -- | -- | -- |
| Net Income | (30.26) | (35.50) | (33.38) | 1.97 | (0.02) |
| Basic EPS | (0.26) | -- | -- | -- | 0.00 |
| Diluted EPS | (0.26) | -- | -- | -- | 0.00 |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 |
|---|
| Operating Cash Flow | (19.16) | (0.43) | (1.08) | (0.76) | 0.00 |
| Investing Cash Flow | (433.06) | 0.00 | 0.00 | (414.00) | -- |
| Financing Cash Flow | 525.16 | 0.00 | (0.02) | 415.99 | -- |
